TI
CGON icon

Tidal Investments’s CG Oncology CGON Stock Holding History

Tidal Investments’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.88M Buy
68,702
+5,539
+9% +$362K 0.01% 952
2026
Q1 		$4.27M Buy
+63,163
New +$3.58M 0.01% 862

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Tidal Investments's CGON Position: Q2 2026 in Review

Tidal Investments increased its CG Oncology (CGON) stake by 8.8% in Q2 2026, buying an estimated $362K and bringing the position to 68,702 shares worth $4.88M. The position accounts for 0.01% of the portfolio, ranked #952.

Tidal Investments first reported a position in CGON in Q1 2026 and has held it in 2 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Tidal Investments held 68,702 shares of CG Oncology worth $4.88M as of Q2 2026.
  • Tidal Investments bought 5,539 CG Oncology shares in Q2 2026, an estimated $362K.
  • CG Oncology made up 0.01% of Tidal Investments's portfolio in Q2 2026, its #952 holding.
  • Tidal Investments first reported a position in CG Oncology in Q1 2026 and has held it in 2 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.